73 related articles for article (PubMed ID: 3820681)
1. [Contrast-enhanced MRI and contrast medium development].
Iio M
Nihon Rinsho; 1987 Jan; 45(1):28-32. PubMed ID: 3820681
[No Abstract] [Full Text] [Related]
2. The role of gadolinium-diethylenetriaminepentaacetic acid in the evaluation of the central nervous system.
Runge VM; Gelblum DY
Magn Reson Q; 1990 Apr; 6(2):85-107. PubMed ID: 2202425
[No Abstract] [Full Text] [Related]
3. [The enhancement effects of Gd-DTPA for cerebrospinal lesions-- comparison with conventional T2-weighted images].
Mano I; Yoshida H; Kono T; Tsuchida T; Terao H; Iio M
Rinsho Hoshasen; 1987 Dec; 32(13):1547-53. PubMed ID: 3448287
[No Abstract] [Full Text] [Related]
4. Gadolinium-DTPA enhancement of experimental soft tissue carcinoma and hemorrhage in magnetic resonance imaging.
Pettersson H; Ackerman N; Kaude J; Googe RE; Mancuso AA; Scott KN; Hackett RH; Hager DA; Caballero S
Acta Radiol; 1987; 28(1):75-8. PubMed ID: 2952147
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging of local soft tissue inflammation using gadolinium-DTPA.
Paajanen H; Brasch RC; Schmiedl U; Ogan M
Acta Radiol; 1987; 28(1):79-83. PubMed ID: 2952148
[TBL] [Abstract][Full Text] [Related]
6. [Gadolinium-DTPA (Magnevist) as contrast medium for galactography].
Kaltenborn H; Schadmand S; Beck T; Thelen M
Rofo; 1995 Nov; 163(5):457-9. PubMed ID: 8527765
[No Abstract] [Full Text] [Related]
7. Future applications of contrast agents for magnetic resonance imaging of the central nervous system.
Bradley WG
Invest Radiol; 1992 Aug; 27 Suppl 1():S58-60. PubMed ID: 1506155
[No Abstract] [Full Text] [Related]
8. [The value of gadolinium-DTPA in the study of the urinary bladder].
Beyer HK; Blümm R; Hötzinger H
Rontgenpraxis; 1988 Feb; 41(2):57-64. PubMed ID: 3363435
[No Abstract] [Full Text] [Related]
9. Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging.
Gonzalez-Scarano F; Grossman RI; Galetta S; Atlas SW; Silberberg DH
Ann Neurol; 1987 Mar; 21(3):300-6. PubMed ID: 3606036
[TBL] [Abstract][Full Text] [Related]
10. [Visualization of multiple neurofibromas using gadolinium-DTPA assisted MRT: a case report].
Kaminsky S; Schulz B
Rontgenblatter; 1988 Dec; 41(12):492-4. PubMed ID: 3145555
[TBL] [Abstract][Full Text] [Related]
11. [Oral contrast medium for magnetic resonance tomography of the abdomen. II. Phase I clinical testing of gadolinium-DTPA].
Kornmesser W; Laniado M; Hamm B; Clauss W; Weinmann HJ; Schulz E; Wolf KJ; Felix R
Rofo; 1987 Nov; 147(5):550-6. PubMed ID: 2825293
[TBL] [Abstract][Full Text] [Related]
12. Gadolinium-labeled liposomes: targeted MR contrast agents for the liver and spleen.
Kabalka G; Buonocore E; Hubner K; Moss T; Norley N; Huang L
Radiology; 1987 Apr; 163(1):255-8. PubMed ID: 3454163
[TBL] [Abstract][Full Text] [Related]
13. [Magnetic resonance tomography of non-acute multiple sclerosis before and after use of a contrast medium (Gd-DTPA)].
Gowin W; Weihe W; Appel C; Mariss G
Rontgenpraxis; 1986 Nov; 39(11):367-77. PubMed ID: 3810314
[No Abstract] [Full Text] [Related]
14. Technical advances in magnetic resonance imaging.
Bydder GM
Curr Opin Neurol Neurosurg; 1992 Dec; 5(6):854-8. PubMed ID: 1467578
[TBL] [Abstract][Full Text] [Related]
15. Indications for gadolinium-DTPA in magnetic resonance evaluation of extracranial head and neck mass lesions: review of experience with 27 patients examined with a 2 tesla imager.
Chisin R; Gomori JM; Elidan J
Isr J Med Sci; 1992; 28(3-4):268-76. PubMed ID: 1592599
[TBL] [Abstract][Full Text] [Related]
16. Hepatic haemangioma: dynamic MRI using gadolinium-DTPA.
Ohtomo K; Itai Y; Yoshikawa K; Kokubo T; Yashiro N; Iio M
Eur J Radiol; 1987 Nov; 7(4):257-9. PubMed ID: 3691543
[TBL] [Abstract][Full Text] [Related]
17. [Acoustic neurinomas. Magnetic resonance tomography using the contrast medium Gd-DTPA].
Pronin IN; Kornienko VN
Zh Vopr Neirokhir Im N N Burdenko; 1995; (2):16-7. PubMed ID: 7625134
[TBL] [Abstract][Full Text] [Related]
18. Use of gadolinium-DTPA as a myocardial perfusion agent: potential applications and limitations for magnetic resonance imaging.
Johnston DL; Liu P; Lauffer RB; Newell JB; Wedeen VJ; Rosen BR; Brady TJ; Okada RD
J Nucl Med; 1987 May; 28(5):871-7. PubMed ID: 3572546
[TBL] [Abstract][Full Text] [Related]
19. [Gadolinium-DTPA as an oral contrast medium for magnetic resonance tomography of the pancreas].
Neumann K; Kaminsky S; Gogoll M; Clauss W; Langer M; Felix R
Rofo; 1991 Mar; 154(3):262-8. PubMed ID: 1849293
[TBL] [Abstract][Full Text] [Related]
20. [MRI of the nasopharynx with Gd-DTPA: its value and differential diagnostic criteria].
Vogl T; Dresel S; Schedel H; Markl A; Grevers G; Stelzer S; Lissner J
Rofo; 1989 May; 150(5):516-22. PubMed ID: 2541475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
